[
    {
        "id": 10320,
        "drug_name": "Nitrofurantoin Oral Suspension USP - (Furadantin generic)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Urinary tract infections",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/131225",
        "note": "Approved April 24, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10329,
        "drug_name": "Tofersen",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/QTRX\/news\/131793",
        "note": "Approved April 25, 2023.",
        "company_entity_id": 1397,
        "company_ticker": "QTRX",
        "company_name": "Quanterix Corporation",
        "company_price": "26.8100",
        "company_change": 0.46,
        "company_percent_change": 1.75,
        "company_optionable": 1,
        "company_number_of_shares": 38063618,
        "price_change_sparkline": [
            [
                22.09,
                1706677200
            ],
            [
                23.13,
                1706763600
            ],
            [
                23.1,
                1706850000
            ],
            [
                23.44,
                1707109200
            ],
            [
                24.01,
                1707195600
            ],
            [
                23.77,
                1707282000
            ],
            [
                24.35,
                1707368400
            ],
            [
                24.28,
                1707454800
            ],
            [
                24.44,
                1707714000
            ],
            [
                23.96,
                1707800400
            ],
            [
                24.68,
                1707886800
            ],
            [
                26.23,
                1707973200
            ],
            [
                26.2,
                1708059600
            ],
            [
                26.07,
                1708405200
            ],
            [
                25.78,
                1708491600
            ],
            [
                25.51,
                1708578000
            ],
            [
                24.87,
                1708664400
            ],
            [
                25.09,
                1708923600
            ],
            [
                24.17,
                1709010000
            ],
            [
                23.48,
                1709096400
            ],
            [
                23.96,
                1709182800
            ],
            [
                27,
                1709269200
            ],
            [
                28.07,
                1709528400
            ],
            [
                28.21,
                1709614800
            ],
            [
                28.28,
                1709701200
            ],
            [
                28.05,
                1709787600
            ],
            [
                26.54,
                1709874000
            ],
            [
                26.35,
                1710129600
            ],
            [
                26.81,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5057,
        "drug_name": "QALSODY (Tofersen)",
        "clinical_trial_id": "NCT02623699",
        "has_trial_insight_page": 1,
        "indication": "Amyotrophic lateral sclerosis (SOD1-ALS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-25",
        "link": "https:\/\/investors.biogen.com\/news-releases\/news-release-details\/fda-grants-accelerated-approval-qalsodytm-tofersen-sod1-als",
        "note": "FDA granted accelerated approval on April 25, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "227.3600",
        "company_change": -2.71,
        "company_percent_change": -1.1800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ],
            [
                223.71,
                1708923600
            ],
            [
                223.94,
                1709010000
            ],
            [
                221.74,
                1709096400
            ],
            [
                216.99,
                1709182800
            ],
            [
                220.95,
                1709269200
            ],
            [
                221.02,
                1709528400
            ],
            [
                217.23,
                1709614800
            ],
            [
                217.56,
                1709701200
            ],
            [
                219.36,
                1709787600
            ],
            [
                223.24,
                1709874000
            ],
            [
                230.07,
                1710129600
            ],
            [
                227.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5057,
        "drug_name": "QALSODY (Tofersen)",
        "clinical_trial_id": "NCT02623699",
        "has_trial_insight_page": 1,
        "indication": "Amyotrophic lateral sclerosis (SOD1-ALS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-25",
        "link": "https:\/\/investors.biogen.com\/news-releases\/news-release-details\/fda-grants-accelerated-approval-qalsodytm-tofersen-sod1-als",
        "note": "FDA granted accelerated approval on April 25, 2023.",
        "company_entity_id": 173,
        "company_ticker": "IONS",
        "company_name": "Ionis Pharmaceuticals Inc.",
        "company_price": "43.1700",
        "company_change": -0.08999999999999997,
        "company_percent_change": -0.20999999999999996,
        "company_optionable": 1,
        "company_number_of_shares": 145751797,
        "price_change_sparkline": [
            [
                51.39,
                1706677200
            ],
            [
                50.97,
                1706763600
            ],
            [
                49.75,
                1706850000
            ],
            [
                49.43,
                1707109200
            ],
            [
                49.12,
                1707195600
            ],
            [
                49.54,
                1707282000
            ],
            [
                49.98,
                1707368400
            ],
            [
                51.4,
                1707454800
            ],
            [
                50.38,
                1707714000
            ],
            [
                48.61,
                1707800400
            ],
            [
                49.07,
                1707886800
            ],
            [
                45.28,
                1707973200
            ],
            [
                44.43,
                1708059600
            ],
            [
                44.35,
                1708405200
            ],
            [
                43.53,
                1708491600
            ],
            [
                43.98,
                1708578000
            ],
            [
                45.36,
                1708664400
            ],
            [
                46.1,
                1708923600
            ],
            [
                47.41,
                1709010000
            ],
            [
                46.54,
                1709096400
            ],
            [
                45.21,
                1709182800
            ],
            [
                45.46,
                1709269200
            ],
            [
                44.87,
                1709528400
            ],
            [
                44.19,
                1709614800
            ],
            [
                44.29,
                1709701200
            ],
            [
                44.67,
                1709787600
            ],
            [
                43.99,
                1709874000
            ],
            [
                43.26,
                1710129600
            ],
            [
                43.17,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3629,
        "drug_name": "Vowst (SER-109)",
        "clinical_trial_id": "NCT03183141",
        "has_trial_insight_page": 0,
        "indication": "Recurrent C. Difficile infection",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-26",
        "link": "https:\/\/www.statnews.com\/2023\/04\/26\/microbiome-drug-vowst-c-diff-seres-fda\/",
        "note": "Approved April 26, 2023.",
        "company_entity_id": 192,
        "company_ticker": "MCRB",
        "company_name": "Seres Therapeutics Inc.",
        "company_price": "0.7730",
        "company_change": -0.08999999999999997,
        "company_percent_change": -10.12,
        "company_optionable": 1,
        "company_number_of_shares": 151009462,
        "price_change_sparkline": [
            [
                1.13,
                1706677200
            ],
            [
                1.15,
                1706763600
            ],
            [
                1.1,
                1706850000
            ],
            [
                1.09,
                1707109200
            ],
            [
                1.1,
                1707195600
            ],
            [
                1.02,
                1707282000
            ],
            [
                1.035,
                1707368400
            ],
            [
                1.12,
                1707454800
            ],
            [
                1.15,
                1707714000
            ],
            [
                1.06,
                1707800400
            ],
            [
                1.1,
                1707886800
            ],
            [
                1.12,
                1707973200
            ],
            [
                1.05,
                1708059600
            ],
            [
                1.04,
                1708405200
            ],
            [
                1.05,
                1708491600
            ],
            [
                1.1,
                1708578000
            ],
            [
                1.06,
                1708664400
            ],
            [
                1.07,
                1708923600
            ],
            [
                1.14,
                1709010000
            ],
            [
                1.15,
                1709096400
            ],
            [
                1.14,
                1709182800
            ],
            [
                1.23,
                1709269200
            ],
            [
                1.14,
                1709528400
            ],
            [
                1.06,
                1709614800
            ],
            [
                1.01,
                1709701200
            ],
            [
                0.98,
                1709787600
            ],
            [
                0.9705,
                1709874000
            ],
            [
                0.86,
                1710129600
            ],
            [
                0.773,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 6759,
        "drug_name": "20vPnC",
        "clinical_trial_id": "NCT04382326",
        "has_trial_insight_page": 1,
        "indication": "Pneumococcal Disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/132482",
        "note": "Approved on April 27, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            },
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 7244,
        "drug_name": "UZEDY (risperidone)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Schizophrenia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TEVA\/news\/132781",
        "note": "Approved April 28, 2023.",
        "company_entity_id": 390,
        "company_ticker": "TEVA",
        "company_name": "Teva Pharmaceutical Industries Limited American Depositary Shares",
        "company_price": "13.4900",
        "company_change": 0.14,
        "company_percent_change": 1.05,
        "company_optionable": 1,
        "company_number_of_shares": 1121094011,
        "price_change_sparkline": [
            [
                12.1,
                1706677200
            ],
            [
                12.46,
                1706763600
            ],
            [
                12.28,
                1706850000
            ],
            [
                12.38,
                1707109200
            ],
            [
                12.25,
                1707195600
            ],
            [
                12.14,
                1707282000
            ],
            [
                12.09,
                1707368400
            ],
            [
                12.01,
                1707454800
            ],
            [
                12.91,
                1707714000
            ],
            [
                12.92,
                1707800400
            ],
            [
                13.17,
                1707886800
            ],
            [
                13.2,
                1707973200
            ],
            [
                13.02,
                1708059600
            ],
            [
                13.07,
                1708405200
            ],
            [
                13,
                1708491600
            ],
            [
                13.05,
                1708578000
            ],
            [
                12.89,
                1708664400
            ],
            [
                13.29,
                1708923600
            ],
            [
                13.3,
                1709010000
            ],
            [
                13.09,
                1709096400
            ],
            [
                13.15,
                1709182800
            ],
            [
                13.5,
                1709269200
            ],
            [
                13.44,
                1709528400
            ],
            [
                13.54,
                1709614800
            ],
            [
                13.53,
                1709701200
            ],
            [
                13.71,
                1709787600
            ],
            [
                13.62,
                1709874000
            ],
            [
                13.35,
                1710129600
            ],
            [
                13.49,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2837,
        "drug_name": "Somapacitan (NN8640)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Growth Hormone Deficiency (GHD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-04-28",
        "link": "https:\/\/www.novonordisk-us.com\/media\/news-archive\/news-details.html?id=166098",
        "note": "Approved April 28, 2023.",
        "company_entity_id": 385,
        "company_ticker": "NVO",
        "company_name": "Novo Nordisk A\/S",
        "company_price": "135.1100",
        "company_change": 3.87,
        "company_percent_change": 2.95,
        "company_optionable": 1,
        "company_number_of_shares": 4510000000,
        "price_change_sparkline": [
            [
                114.74,
                1706677200
            ],
            [
                115.79,
                1706763600
            ],
            [
                113.7,
                1706850000
            ],
            [
                118.26,
                1707109200
            ],
            [
                117.61,
                1707195600
            ],
            [
                118.66,
                1707282000
            ],
            [
                118.39,
                1707368400
            ],
            [
                121.2,
                1707454800
            ],
            [
                120.53,
                1707714000
            ],
            [
                119.99,
                1707800400
            ],
            [
                123.29,
                1707886800
            ],
            [
                121.75,
                1707973200
            ],
            [
                124.01,
                1708059600
            ],
            [
                121.45,
                1708405200
            ],
            [
                120.93,
                1708491600
            ],
            [
                124.52,
                1708578000
            ],
            [
                123.45,
                1708664400
            ],
            [
                123.49,
                1708923600
            ],
            [
                122.23,
                1709010000
            ],
            [
                121.54,
                1709096400
            ],
            [
                119.77,
                1709182800
            ],
            [
                124.23,
                1709269200
            ],
            [
                127.95,
                1709528400
            ],
            [
                124.65,
                1709614800
            ],
            [
                124.75,
                1709701200
            ],
            [
                135.92,
                1709787600
            ],
            [
                133.07,
                1709874000
            ],
            [
                131.24,
                1710129600
            ],
            [
                135.11,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3528,
        "drug_name": "LUMRYZ\u2122 (sodium oxybate)",
        "clinical_trial_id": "NCT02720744",
        "has_trial_insight_page": 0,
        "indication": "Excessive daytime sleepiness and cataplexy in patients suffering from narcolepsy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-01",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AVDL\/news\/133128",
        "note": "Final approval granted by FDA on May 1, 2023.",
        "company_entity_id": 365,
        "company_ticker": "AVDL",
        "company_name": "Avadel Pharmaceuticals plc",
        "company_price": "15.9700",
        "company_change": -0.030000000000000027,
        "company_percent_change": -0.18999999999999995,
        "company_optionable": 1,
        "company_number_of_shares": 90576998,
        "price_change_sparkline": [
            [
                14.39,
                1706677200
            ],
            [
                14.72,
                1706763600
            ],
            [
                14.69,
                1706850000
            ],
            [
                14.55,
                1707109200
            ],
            [
                15.4,
                1707195600
            ],
            [
                14.71,
                1707282000
            ],
            [
                14.7,
                1707368400
            ],
            [
                14.42,
                1707454800
            ],
            [
                14.65,
                1707714000
            ],
            [
                14.15,
                1707800400
            ],
            [
                14.25,
                1707886800
            ],
            [
                14.2,
                1707973200
            ],
            [
                13.57,
                1708059600
            ],
            [
                12.86,
                1708405200
            ],
            [
                12.68,
                1708491600
            ],
            [
                12.6,
                1708578000
            ],
            [
                12.62,
                1708664400
            ],
            [
                12.99,
                1708923600
            ],
            [
                13.31,
                1709010000
            ],
            [
                12.55,
                1709096400
            ],
            [
                12.78,
                1709182800
            ],
            [
                13.72,
                1709269200
            ],
            [
                16.13,
                1709528400
            ],
            [
                15.81,
                1709614800
            ],
            [
                16.32,
                1709701200
            ],
            [
                16.035,
                1709787600
            ],
            [
                16.35,
                1709874000
            ],
            [
                16,
                1710129600
            ],
            [
                15.97,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9488,
        "drug_name": "AREXVY",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "RSV vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GSK\/news\/133945",
        "note": "FDA Approved on May 3, 2023.",
        "company_entity_id": 324,
        "company_ticker": "AGEN",
        "company_name": "Agenus Inc.",
        "company_price": "0.6692",
        "company_change": 0,
        "company_percent_change": -0.62,
        "company_optionable": 1,
        "company_number_of_shares": 381495471,
        "price_change_sparkline": [
            [
                0.6672,
                1706677200
            ],
            [
                0.6352,
                1706763600
            ],
            [
                0.6372,
                1706850000
            ],
            [
                0.6323,
                1707109200
            ],
            [
                0.7043,
                1707195600
            ],
            [
                0.6799,
                1707282000
            ],
            [
                0.6973,
                1707368400
            ],
            [
                0.7481,
                1707454800
            ],
            [
                0.8093,
                1707714000
            ],
            [
                0.7601,
                1707800400
            ],
            [
                0.9279,
                1707886800
            ],
            [
                0.6538,
                1707973200
            ],
            [
                0.6551,
                1708059600
            ],
            [
                0.6684,
                1708405200
            ],
            [
                0.6592,
                1708491600
            ],
            [
                0.675,
                1708578000
            ],
            [
                0.6821,
                1708664400
            ],
            [
                0.7255,
                1708923600
            ],
            [
                0.7778,
                1709010000
            ],
            [
                0.7512,
                1709096400
            ],
            [
                0.67,
                1709182800
            ],
            [
                0.6601,
                1709269200
            ],
            [
                0.6821,
                1709528400
            ],
            [
                0.6722,
                1709614800
            ],
            [
                0.7,
                1709701200
            ],
            [
                0.7012,
                1709787600
            ],
            [
                0.6701,
                1709874000
            ],
            [
                0.67,
                1710129600
            ],
            [
                0.6692,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9488,
        "drug_name": "AREXVY",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "RSV vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GSK\/news\/133945",
        "note": "FDA Approved on May 3, 2023.",
        "company_entity_id": 379,
        "company_ticker": "GSK",
        "company_name": "GSK plc American Depositary Shares (Each representing two)",
        "company_price": "43.2700",
        "company_change": 0.35,
        "company_percent_change": 0.82,
        "company_optionable": 1,
        "company_number_of_shares": 2058516719,
        "price_change_sparkline": [
            [
                39.0637603938206,
                1706677200
            ],
            [
                40.2424083367376,
                1706763600
            ],
            [
                40.3315497777986,
                1706850000
            ],
            [
                41.1734411655964,
                1707109200
            ],
            [
                41.3517240477183,
                1707195600
            ],
            [
                41.6191483709012,
                1707282000
            ],
            [
                41.4210562796546,
                1707368400
            ],
            [
                41.5101977207156,
                1707454800
            ],
            [
                40.67821093748,
                1707714000
            ],
            [
                40.9951582834745,
                1707800400
            ],
            [
                41.40124707053,
                1707886800
            ],
            [
                41.371533256843,
                1707973200
            ],
            [
                41.5399115344025,
                1708059600
            ],
            [
                41.6191483709012,
                1708405200
            ],
            [
                41.5399115344025,
                1708491600
            ],
            [
                42.16,
                1708578000
            ],
            [
                42.22,
                1708664400
            ],
            [
                42.34,
                1708923600
            ],
            [
                42.38,
                1709010000
            ],
            [
                42.34,
                1709096400
            ],
            [
                41.9,
                1709182800
            ],
            [
                42.03,
                1709269200
            ],
            [
                42.44,
                1709528400
            ],
            [
                42.6,
                1709614800
            ],
            [
                42.62,
                1709701200
            ],
            [
                43.58,
                1709787600
            ],
            [
                43.14,
                1709874000
            ],
            [
                42.92,
                1710129600
            ],
            [
                43.27,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10352,
        "drug_name": "KALYDECO (ivacaftor)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Children with cystic fibrosis (CF) ages 1 month to less than four months old",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VRTX\/news\/134062",
        "note": "FDA approved on May 3, 2023.",
        "company_entity_id": 306,
        "company_ticker": "VRTX",
        "company_name": "Vertex Pharmaceuticals Incorporated",
        "company_price": "412.4500",
        "company_change": -2.02,
        "company_percent_change": -0.49,
        "company_optionable": 1,
        "company_number_of_shares": 258307816,
        "price_change_sparkline": [
            [
                433.38,
                1706677200
            ],
            [
                433.87,
                1706763600
            ],
            [
                424.68,
                1706850000
            ],
            [
                428.89,
                1707109200
            ],
            [
                416.13,
                1707195600
            ],
            [
                419.08,
                1707282000
            ],
            [
                423.06,
                1707368400
            ],
            [
                422.91,
                1707454800
            ],
            [
                418.53,
                1707714000
            ],
            [
                416.04,
                1707800400
            ],
            [
                417.88,
                1707886800
            ],
            [
                426.29,
                1707973200
            ],
            [
                422.2,
                1708059600
            ],
            [
                420.64,
                1708405200
            ],
            [
                419.63,
                1708491600
            ],
            [
                426.78,
                1708578000
            ],
            [
                430.11,
                1708664400
            ],
            [
                433.48,
                1708923600
            ],
            [
                430.92,
                1709010000
            ],
            [
                426.97,
                1709096400
            ],
            [
                420.74,
                1709182800
            ],
            [
                432.76,
                1709269200
            ],
            [
                424.03,
                1709528400
            ],
            [
                415.44,
                1709614800
            ],
            [
                411.85,
                1709701200
            ],
            [
                410.54,
                1709787600
            ],
            [
                413.59,
                1709874000
            ],
            [
                414.47,
                1710129600
            ],
            [
                412.45,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4466,
        "drug_name": "MydCombi",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Mydriasis - pupil dilation",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-08",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/EYEN\/news\/134872",
        "note": "Approved May 8, 2023.",
        "company_entity_id": 531,
        "company_ticker": "EYEN",
        "company_name": "Eyenovia Inc.",
        "company_price": "1.6500",
        "company_change": 0.07,
        "company_percent_change": 4.43,
        "company_optionable": 1,
        "company_number_of_shares": 44122225,
        "price_change_sparkline": [
            [
                1.82,
                1706677200
            ],
            [
                1.9,
                1706763600
            ],
            [
                1.81,
                1706850000
            ],
            [
                1.75,
                1707109200
            ],
            [
                1.79,
                1707195600
            ],
            [
                1.765,
                1707282000
            ],
            [
                1.775,
                1707368400
            ],
            [
                1.83,
                1707454800
            ],
            [
                1.91,
                1707714000
            ],
            [
                1.8,
                1707800400
            ],
            [
                1.78,
                1707886800
            ],
            [
                1.76,
                1707973200
            ],
            [
                1.7,
                1708059600
            ],
            [
                1.605,
                1708405200
            ],
            [
                1.59,
                1708491600
            ],
            [
                1.67,
                1708578000
            ],
            [
                1.69,
                1708664400
            ],
            [
                1.98,
                1708923600
            ],
            [
                2.16,
                1709010000
            ],
            [
                2.3,
                1709096400
            ],
            [
                2.165,
                1709182800
            ],
            [
                2.37,
                1709269200
            ],
            [
                2.28,
                1709528400
            ],
            [
                1.76,
                1709614800
            ],
            [
                1.695,
                1709701200
            ],
            [
                1.72,
                1709787600
            ],
            [
                1.58,
                1709874000
            ],
            [
                1.58,
                1710129600
            ],
            [
                1.65,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5690,
        "drug_name": "FARXIGA (Dapagliflozin)",
        "clinical_trial_id": "NCT03619213",
        "has_trial_insight_page": 1,
        "indication": "Risk of cardiovascular (CV) death, hospitalization for heart failure (hHF) and urgent heart failure (HF)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AZN\/news\/135381",
        "note": "Approved May 9, 2023.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "67.4000",
        "company_change": -0.27,
        "company_percent_change": -0.4,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ],
            [
                65.93,
                1708923600
            ],
            [
                66.33,
                1709010000
            ],
            [
                65.35,
                1709096400
            ],
            [
                64.16,
                1709182800
            ],
            [
                64.6,
                1709269200
            ],
            [
                64.79,
                1709528400
            ],
            [
                64.81,
                1709614800
            ],
            [
                65.27,
                1709701200
            ],
            [
                66.19,
                1709787600
            ],
            [
                66.5,
                1709874000
            ],
            [
                67.67,
                1710129600
            ],
            [
                67.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5120,
        "drug_name": "Pegunigalsidase alfa  (PRX-102)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Fabry disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-10",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PLX\/news\/135565",
        "note": "Approved May 10, 2023.",
        "company_entity_id": 242,
        "company_ticker": "PLX",
        "company_name": "Protalix BioTherapeutics Inc. (DE)",
        "company_price": "1.4300",
        "company_change": -0.010000000000000009,
        "company_percent_change": -0.69,
        "company_optionable": 1,
        "company_number_of_shares": 72952124,
        "price_change_sparkline": [
            [
                1.45,
                1706677200
            ],
            [
                1.47,
                1706763600
            ],
            [
                1.45,
                1706850000
            ],
            [
                1.44,
                1707109200
            ],
            [
                1.53,
                1707195600
            ],
            [
                1.48,
                1707282000
            ],
            [
                1.5,
                1707368400
            ],
            [
                1.47,
                1707454800
            ],
            [
                1.49,
                1707714000
            ],
            [
                1.42,
                1707800400
            ],
            [
                1.48,
                1707886800
            ],
            [
                1.52,
                1707973200
            ],
            [
                1.47,
                1708059600
            ],
            [
                1.44,
                1708405200
            ],
            [
                1.42,
                1708491600
            ],
            [
                1.43,
                1708578000
            ],
            [
                1.45,
                1708664400
            ],
            [
                1.49,
                1708923600
            ],
            [
                1.56,
                1709010000
            ],
            [
                1.54,
                1709096400
            ],
            [
                1.63,
                1709182800
            ],
            [
                1.62,
                1709269200
            ],
            [
                1.57,
                1709528400
            ],
            [
                1.52,
                1709614800
            ],
            [
                1.48,
                1709701200
            ],
            [
                1.46,
                1709787600
            ],
            [
                1.49,
                1709874000
            ],
            [
                1.44,
                1710129600
            ],
            [
                1.45,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10370,
        "drug_name": "Methsuximide Capsules USP (Celontin generics)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Absence seizures that are refractory to other drugs",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/136536",
        "note": "ANDA approved May 15, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10371,
        "drug_name": "Alendronate Sodium Oral Solution (RLD Fosamax generic)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Osteoporosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/136536",
        "note": "ANDA approved May 15, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10374,
        "drug_name": "Caldolor",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Pain and fever in patients three months to six months of age",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CPIX\/news\/136648",
        "note": "Expanded label approval by FDA on May 15, 2023.",
        "company_entity_id": 760,
        "company_ticker": "CPIX",
        "company_name": "Cumberland Pharmaceuticals Inc.",
        "company_price": "1.8200",
        "company_change": -0.20999999999999996,
        "company_percent_change": -10.12,
        "company_optionable": 1,
        "company_number_of_shares": 14255700,
        "price_change_sparkline": [
            [
                2.08,
                1706677200
            ],
            [
                2.01,
                1706763600
            ],
            [
                2.03,
                1706850000
            ],
            [
                1.97,
                1707109200
            ],
            [
                1.97,
                1707195600
            ],
            [
                1.97,
                1707282000
            ],
            [
                2.04,
                1707368400
            ],
            [
                2.12,
                1707454800
            ],
            [
                2.05,
                1707714000
            ],
            [
                2.01,
                1707800400
            ],
            [
                2.1,
                1707886800
            ],
            [
                2.0602,
                1707973200
            ],
            [
                2.1,
                1708059600
            ],
            [
                2.1,
                1708405200
            ],
            [
                2.13,
                1708491600
            ],
            [
                2.21,
                1708578000
            ],
            [
                2.14,
                1708664400
            ],
            [
                2.21,
                1708923600
            ],
            [
                2.13,
                1709010000
            ],
            [
                2.2,
                1709096400
            ],
            [
                2.13,
                1709182800
            ],
            [
                2.12,
                1709269200
            ],
            [
                2.03,
                1709528400
            ],
            [
                2,
                1709614800
            ],
            [
                1.94,
                1709701200
            ],
            [
                2.1,
                1709787600
            ],
            [
                2.03,
                1709874000
            ],
            [
                2.03,
                1710129600
            ],
            [
                1.82,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10375,
        "drug_name": "JUV\u00c9DERM - (SKINVIVE) (injectable HA)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Botox in the cheeks",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/136634",
        "note": "FDA Approved on May 15, 2023.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "180.9200",
        "company_change": 1.29,
        "company_percent_change": 0.72,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ],
            [
                178.81,
                1708923600
            ],
            [
                178.99,
                1709010000
            ],
            [
                178,
                1709096400
            ],
            [
                176.05,
                1709182800
            ],
            [
                178.91,
                1709269200
            ],
            [
                177.05,
                1709528400
            ],
            [
                179.16,
                1709614800
            ],
            [
                181.06,
                1709701200
            ],
            [
                180.57,
                1709787600
            ],
            [
                178.85,
                1709874000
            ],
            [
                179.63,
                1710129600
            ],
            [
                180.92,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7419,
        "drug_name": "RINVOQ (upadacitinib)",
        "clinical_trial_id": "NCT03345836",
        "has_trial_insight_page": 0,
        "indication": "Crohn's disease (induction\/maintenance)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-18",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/137490",
        "note": "Approved May 18, 2023.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "180.9200",
        "company_change": 1.29,
        "company_percent_change": 0.72,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ],
            [
                178.81,
                1708923600
            ],
            [
                178.99,
                1709010000
            ],
            [
                178,
                1709096400
            ],
            [
                176.05,
                1709182800
            ],
            [
                178.91,
                1709269200
            ],
            [
                177.05,
                1709528400
            ],
            [
                179.16,
                1709614800
            ],
            [
                181.06,
                1709701200
            ],
            [
                180.57,
                1709787600
            ],
            [
                178.85,
                1709874000
            ],
            [
                179.63,
                1710129600
            ],
            [
                180.92,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 1937,
        "drug_name": "VYJUVEK (beremagene geperpavec-svdt)",
        "clinical_trial_id": "NCT04491604",
        "has_trial_insight_page": 0,
        "indication": "Epidermolysis Bullosa",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-19",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/KRYS\/news\/137675",
        "note": "Approved May 19, 2023.",
        "company_entity_id": 485,
        "company_ticker": "KRYS",
        "company_name": "Krystal Biotech Inc.",
        "company_price": "178.9500",
        "company_change": 8.56,
        "company_percent_change": 5.02,
        "company_optionable": 1,
        "company_number_of_shares": 28292616,
        "price_change_sparkline": [
            [
                111.25,
                1706677200
            ],
            [
                111.56,
                1706763600
            ],
            [
                111.8,
                1706850000
            ],
            [
                111.86,
                1707109200
            ],
            [
                114.77,
                1707195600
            ],
            [
                111.19,
                1707282000
            ],
            [
                111.03,
                1707368400
            ],
            [
                111.36,
                1707454800
            ],
            [
                115.88,
                1707714000
            ],
            [
                108.73,
                1707800400
            ],
            [
                110.13,
                1707886800
            ],
            [
                113.38,
                1707973200
            ],
            [
                113.57,
                1708059600
            ],
            [
                111.64,
                1708405200
            ],
            [
                108.01,
                1708491600
            ],
            [
                111.96,
                1708578000
            ],
            [
                111.33,
                1708664400
            ],
            [
                157,
                1708923600
            ],
            [
                170.15,
                1709010000
            ],
            [
                163.08,
                1709096400
            ],
            [
                159.47,
                1709182800
            ],
            [
                167.82,
                1709269200
            ],
            [
                159.95,
                1709528400
            ],
            [
                170.84,
                1709614800
            ],
            [
                174.36,
                1709701200
            ],
            [
                169.48,
                1709787600
            ],
            [
                171.84,
                1709874000
            ],
            [
                170.39,
                1710129600
            ],
            [
                178.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9056,
        "drug_name": "EPKINLY (epcoritamab-bysp)",
        "clinical_trial_id": "NCT03625037",
        "has_trial_insight_page": 0,
        "indication": "Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-19",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/137658",
        "note": "Approved May 19, 2023.",
        "company_entity_id": 845,
        "company_ticker": "ADPT",
        "company_name": "Adaptive Biotechnologies Corporation",
        "company_price": "3.5900",
        "company_change": -0.18999999999999995,
        "company_percent_change": -5.03,
        "company_optionable": 1,
        "company_number_of_shares": 145092271,
        "price_change_sparkline": [
            [
                3.67,
                1706677200
            ],
            [
                3.74,
                1706763600
            ],
            [
                3.65,
                1706850000
            ],
            [
                3.46,
                1707109200
            ],
            [
                3.77,
                1707195600
            ],
            [
                3.57,
                1707282000
            ],
            [
                3.67,
                1707368400
            ],
            [
                3.78,
                1707454800
            ],
            [
                3.92,
                1707714000
            ],
            [
                3.62,
                1707800400
            ],
            [
                3.94,
                1707886800
            ],
            [
                3.96,
                1707973200
            ],
            [
                3.85,
                1708059600
            ],
            [
                3.85,
                1708405200
            ],
            [
                3.82,
                1708491600
            ],
            [
                3.88,
                1708578000
            ],
            [
                4.04,
                1708664400
            ],
            [
                4.16,
                1708923600
            ],
            [
                4.27,
                1709010000
            ],
            [
                4.15,
                1709096400
            ],
            [
                4.11,
                1709182800
            ],
            [
                4.03,
                1709269200
            ],
            [
                3.99,
                1709528400
            ],
            [
                3.78,
                1709614800
            ],
            [
                3.61,
                1709701200
            ],
            [
                3.45,
                1709787600
            ],
            [
                3.65,
                1709874000
            ],
            [
                3.78,
                1710129600
            ],
            [
                3.59,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9056,
        "drug_name": "EPKINLY (epcoritamab-bysp)",
        "clinical_trial_id": "NCT03625037",
        "has_trial_insight_page": 0,
        "indication": "Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-19",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/137658",
        "note": "Approved May 19, 2023.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "180.9200",
        "company_change": 1.29,
        "company_percent_change": 0.72,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ],
            [
                178.81,
                1708923600
            ],
            [
                178.99,
                1709010000
            ],
            [
                178,
                1709096400
            ],
            [
                176.05,
                1709182800
            ],
            [
                178.91,
                1709269200
            ],
            [
                177.05,
                1709528400
            ],
            [
                179.16,
                1709614800
            ],
            [
                181.06,
                1709701200
            ],
            [
                180.57,
                1709787600
            ],
            [
                178.85,
                1709874000
            ],
            [
                179.63,
                1710129600
            ],
            [
                180.92,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9056,
        "drug_name": "EPKINLY (epcoritamab-bysp)",
        "clinical_trial_id": "NCT03625037",
        "has_trial_insight_page": 0,
        "indication": "Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-05-19",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ABBV\/news\/137658",
        "note": "Approved May 19, 2023.",
        "company_entity_id": 684,
        "company_ticker": "GMAB",
        "company_name": "Genmab A\/S",
        "company_price": "31.4300",
        "company_change": -0.25,
        "company_percent_change": -0.79,
        "company_optionable": 1,
        "company_number_of_shares": 660745350,
        "price_change_sparkline": [
            [
                27.61,
                1706677200
            ],
            [
                28.17,
                1706763600
            ],
            [
                27.8,
                1706850000
            ],
            [
                27.57,
                1707109200
            ],
            [
                28.15,
                1707195600
            ],
            [
                27.97,
                1707282000
            ],
            [
                27.79,
                1707368400
            ],
            [
                27.84,
                1707454800
            ],
            [
                27.49,
                1707714000
            ],
            [
                26.43,
                1707800400
            ],
            [
                27.59,
                1707886800
            ],
            [
                28.23,
                1707973200
            ],
            [
                28.71,
                1708059600
            ],
            [
                28.95,
                1708405200
            ],
            [
                28.95,
                1708491600
            ],
            [
                29.11,
                1708578000
            ],
            [
                29.16,
                1708664400
            ],
            [
                29.4,
                1708923600
            ],
            [
                29.05,
                1709010000
            ],
            [
                27.67,
                1709096400
            ],
            [
                27.77,
                1709182800
            ],
            [
                29.29,
                1709269200
            ],
            [
                28.51,
                1709528400
            ],
            [
                28.75,
                1709614800
            ],
            [
                28.86,
                1709701200
            ],
            [
                29.41,
                1709787600
            ],
            [
                30.3,
                1709874000
            ],
            [
                31.68,
                1710129600
            ],
            [
                31.43,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    }
]